Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspective

Area of Science:

• Clinical Pharmacology
• Drug Development
• Regulatory Science

Background:

• Multi-regional clinical trials (MRCTs) are essential for global drug efficacy and safety evaluation.
• Simultaneous worldwide development and registration accelerate patient access to new medical products.
• MRCTs present complex challenges in quality, design, implementation, analysis, and interpretation.

Observation:

• Lessons learned from the design, implementation, analysis, and interpretation of MRCTs are shared.
• Case examples illustrate practical challenges encountered in conducting global trials.
• Current Japanese regulatory guidance for MRCTs is presented.

Findings:

• Successful MRCTs require careful consideration of regional differences and regulatory landscapes.
• Standardized protocols and robust data management are critical for ensuring data integrity.
• Effective cross-cultural communication and collaboration among international sites are vital.

Implications:

• Addressing MRCT challenges can expedite the availability of safe and effective drugs globally.
• Adherence to regulatory guidance enhances the reliability and acceptance of trial data.
• Sharing best practices improves the overall quality and efficiency of international drug development.